SPDR Series Trust SPDR S&P Biotech ETF (XBI): Price and Financial Metrics ETF
XBI Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $82.83 | 52-week high | $103.52 |
Prev. close | $83.48 | 52-week low | $63.80 |
Day low | $81.26 | Volume | 13,784,200 |
Day high | $84.38 | Avg. volume | 11,741,825 |
50-day MA | $93.36 | Dividend yield | 0.02% |
200-day MA | $82.67 |
XBI Stock Price Chart Interactive Chart >
SPDR Series Trust SPDR S&P Biotech ETF (XBI) ETF Bio
The investment objective of the SPDR S&P Biotech ETF is to provide investment results that correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.
XBI ETF Info
Issuer | State Street Global Advisors |
Expense Ratio | 0.35% |
Underlying Index | S&P Biotechnology Select Industry Index |
Asset Class | Equity |
Sector | Health & Biotech ETFs |
Assets Under Management (AUM) | 6.25B |
Net Asset Value (NAV) | $83.38 |
Options? | Yes |
Total Holdings | 141 |
XBI Top Holdings
Symbol | Company | % of Total |
ALPN | ALPINE IMMUNE SCIENCES INC | 1.9% |
RVMD | REVOLUTION MEDICINES INC | 1.28% |
EXAS | EXACT SCIENCES CORP | 1.22% |
BMRN | BIOMARIN PHARMACEUTICAL INC | 1.21% |
CERE | CEREVEL THERAPEUTICS HOLDING | 1.18% |
CYTK | CYTOKINETICS INC | 1.18% |
CRNX | CRINETICS PHARMACEUTICALS IN | 1.17% |
EXEL | EXELIXIS INC | 1.17% |
MRNA | MODERNA INC | 1.14% |
GERN | GERON CORP | 1.13% |
XBI Price Returns
1-mo | -12.99% |
3-mo | -4.85% |
6-mo | 26.56% |
1-year | 0.70% |
3-year | -37.60% |
5-year | -1.74% |
YTD | -7.23% |
2023 | 7.60% |
2022 | -25.87% |
2021 | -20.45% |
2020 | 48.33% |
2019 | 32.56% |
XBI Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |